[go: up one dir, main page]

ZA200704087B - 12-aryl prostaglandin analogs - Google Patents

12-aryl prostaglandin analogs

Info

Publication number
ZA200704087B
ZA200704087B ZA200704087A ZA200704087A ZA200704087B ZA 200704087 B ZA200704087 B ZA 200704087B ZA 200704087 A ZA200704087 A ZA 200704087A ZA 200704087 A ZA200704087 A ZA 200704087A ZA 200704087 B ZA200704087 B ZA 200704087B
Authority
ZA
South Africa
Prior art keywords
prostaglandin analogs
aryl
aryl prostaglandin
analogs
prostaglandin
Prior art date
Application number
ZA200704087A
Other languages
English (en)
Inventor
Donde Yariv
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of ZA200704087B publication Critical patent/ZA200704087B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA200704087A 2004-12-10 2007-05-21 12-aryl prostaglandin analogs ZA200704087B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/009,298 US7091231B2 (en) 2004-12-10 2004-12-10 12-Aryl prostaglandin analogs

Publications (1)

Publication Number Publication Date
ZA200704087B true ZA200704087B (en) 2008-09-25

Family

ID=36578246

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704087A ZA200704087B (en) 2004-12-10 2007-05-21 12-aryl prostaglandin analogs

Country Status (20)

Country Link
US (3) US7091231B2 (ko)
EP (1) EP1819670B1 (ko)
JP (1) JP5342142B2 (ko)
KR (1) KR101367553B1 (ko)
CN (1) CN101107225B (ko)
AR (1) AR052264A1 (ko)
AU (1) AU2005314000B2 (ko)
BR (1) BRPI0518642A2 (ko)
CA (1) CA2589864C (ko)
DK (1) DK1819670T3 (ko)
ES (1) ES2394838T3 (ko)
IL (1) IL183360A (ko)
MX (1) MX2007006690A (ko)
NO (1) NO20072662L (ko)
NZ (1) NZ555352A (ko)
PL (1) PL216197B1 (ko)
RU (1) RU2439055C2 (ko)
TW (1) TWI392666B (ko)
WO (1) WO2006063179A1 (ko)
ZA (1) ZA200704087B (ko)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US7674786B2 (en) * 2005-05-06 2010-03-09 Allergan, Inc. Therapeutic β-lactams
WO2007005176A1 (en) * 2005-06-29 2007-01-11 Allergan, Inc. Pyrrolidinones for the treatment of glaucoma and ocular hypertension
US7585895B2 (en) * 2005-12-06 2009-09-08 Allergan, Inc. Therapeutic substituted cyclopentanes
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7592364B2 (en) * 2006-02-28 2009-09-22 Allergan, Inc. Substituted gamma lactams as therapeutic agents
CA2653110C (en) 2006-03-29 2018-07-31 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US20090016981A1 (en) * 2006-05-03 2009-01-15 Allergan, Inc. Therapeutic compounds
US7491844B2 (en) * 2006-05-04 2009-02-17 Allergan, Inc. Therapeutic cyclopentane derivatives
US7476755B2 (en) 2006-05-04 2009-01-13 Allergan, Inc. Therapeutic compounds
US7547727B2 (en) * 2006-05-22 2009-06-16 Allergan, Inc. Therapeutic cyclopentane derivatives
WO2008028032A2 (en) * 2006-09-01 2008-03-06 Allergan, Inc. Therapeutic substituted hydantoins and related compounds
US7429671B2 (en) * 2006-12-06 2008-09-30 Air Products And Chemicals, Inc. Process for the fluorination of boron hydrides
WO2008091810A1 (en) * 2007-01-22 2008-07-31 Allergan, Inc. Substituted arylcylopentenes as therapeutic agents
WO2008091860A1 (en) 2007-01-22 2008-07-31 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
US9365485B2 (en) 2007-01-25 2016-06-14 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US8722726B2 (en) * 2007-01-25 2014-05-13 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US8377984B2 (en) * 2008-01-29 2013-02-19 Allergan, Inc. Substituted gamma lactams as therapeutic agents
AU2008210559B2 (en) * 2007-01-31 2014-03-06 Allergan, Inc. Substituted gamma lactams as therapeutic agents
NZ598945A (en) * 2007-02-15 2013-08-30 Allergan Inc Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
US7589213B2 (en) * 2007-04-27 2009-09-15 Old David W Therapeutic substituted lactams
JP5524047B2 (ja) * 2007-05-23 2014-06-18 アラーガン インコーポレイテッド 緑内障および眼圧上昇の治療用環状ラクタム類
AU2008302667B2 (en) * 2007-06-15 2014-07-10 Board Of Regents, The University Of Texas System Methods and compositions to inhibit edema factor and adenylyl cyclase
US7947732B2 (en) * 2007-07-13 2011-05-24 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
US7662850B2 (en) * 2007-07-13 2010-02-16 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
US20090062361A1 (en) * 2007-08-30 2009-03-05 Allergan, Inc. Therapeutic hydantoins
RU2481339C2 (ru) * 2007-11-09 2013-05-10 Аллерган, Инк. Замещенные циклопентаны, обладающие простагландиновой активностью
AU2008331597B2 (en) * 2007-11-29 2013-11-28 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7956051B2 (en) * 2008-01-24 2011-06-07 Allergan, Inc. Therapeutic amides and related compounds
US8455547B2 (en) 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US8633310B2 (en) * 2008-02-19 2014-01-21 Allergan, Inc. Therapeutic substituted lactams
US8440819B2 (en) * 2008-02-22 2013-05-14 Allergan, Inc. Therapeutic substituted beta-lactams
US8487091B2 (en) * 2008-03-04 2013-07-16 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7964596B2 (en) 2008-03-07 2011-06-21 Allergan, Inc. Therapeutic compounds
US20090233921A1 (en) * 2008-03-11 2009-09-17 Allergan, Inc. Therapeutic cyclopentane derivatives
US7960379B2 (en) * 2008-03-14 2011-06-14 Allergan, Inc. Therapeutic compounds
US8198318B2 (en) * 2008-03-18 2012-06-12 Allergen, Inc. Therapeutic amides
US7705001B2 (en) * 2008-03-18 2010-04-27 Allergan, Inc Therapeutic substituted gamma lactams
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
US7956055B2 (en) * 2008-03-25 2011-06-07 Allergan, Inc. Substituted gamma lactams as therapeutic agents
WO2009129187A2 (en) * 2008-04-16 2009-10-22 Allergan, Inc. Combination therapy for glaucoma
ES2735217T3 (es) * 2008-04-24 2019-12-17 Allergan Inc Arilciclopentenos sustituidos como agentes terapéuticos
US7964634B2 (en) * 2008-04-24 2011-06-21 Allergan, Inc. Therapeutic compounds
US8263593B2 (en) 2008-04-24 2012-09-11 Allergan, Inc. Therapeutic compounds
EP2288598B1 (en) * 2008-04-24 2012-03-21 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
US7713968B2 (en) * 2008-04-24 2010-05-11 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
WO2009132088A1 (en) * 2008-04-24 2009-10-29 Allergan, Inc. Substituted gamma lactams as therapeutic agents
US7964599B2 (en) 2008-05-09 2011-06-21 Allergan, Inc. Therapeutic compounds
EP2300439A1 (en) 2008-05-09 2011-03-30 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
WO2009137411A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
US8569349B2 (en) * 2008-05-09 2013-10-29 Allergan, Inc. Therapeutic compounds
US8530471B2 (en) * 2008-05-09 2013-09-10 Allergan, Inc. Therapeutic cyclopentane derivatives
EP2285782A2 (en) * 2008-05-09 2011-02-23 Allergan, Inc. Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
WO2009146255A1 (en) * 2008-05-27 2009-12-03 Allergan, Inc. Prostaglandin produgs as hypotensive agents
AU2009249388B2 (en) * 2008-05-20 2014-04-03 Allergan, Inc. Therapeutic lactams
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8952051B2 (en) * 2009-11-05 2015-02-10 Allergan, Inc. Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
US9090584B2 (en) * 2010-01-26 2015-07-28 Allergan, Inc. Therapeutic agents for treatment of ocular hypertension
US8299068B2 (en) * 2010-01-29 2012-10-30 Allergan, Inc. Therapeutically active cyclopentanes
ES2711425T3 (es) * 2012-08-27 2019-05-03 Allergan Inc Espesamiento de la córnea central reducido mediante el uso de profármacos de éster hidrófilos de beta-clorociclopentanos
WO2014194209A1 (en) 2013-05-31 2014-12-04 Allergan, Inc. Substituted cyclopentenes as therapeutic agents
BR112016006951B1 (pt) 2013-09-30 2022-10-04 Patheon Api Services Inc Novas vias de síntese para prostaglandinas e intermediários de prostaglandina com o uso de metátese
CN111978310A (zh) 2014-10-02 2020-11-24 阿勒根公司 γ-内酰胺的酯前药及其用途
KR102069205B1 (ko) * 2017-08-09 2020-01-22 연성정밀화학(주) 라타노프로스틴 부노드의 제조 방법 및 그를 위한 중간체

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066834A (en) * 1974-01-24 1978-01-03 Miles Laboratories, Inc. Cycloalkenyl analogues of prostaglandins E
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4168452A (en) * 1976-06-10 1979-09-18 Zenith Radio Corporation Tetrode section for a unitized, three-beam electron gun having an extended field main focus lens
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
DE3100578A1 (de) * 1980-01-25 1982-02-11 Farmitalia Carlo Erba S.p.A., 20159 Milano Isoxazolyl- und isoxazolinyl-prostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und veterinaermedizinische mittel
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
DE4330177A1 (de) * 1993-08-31 1995-03-02 Schering Ag Neue 9-Chlor-prostaglandin-derivate
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5902726A (en) 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5698598A (en) 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US6090874A (en) * 1995-12-13 2000-07-18 Zeon Chemicals L.P. High clarity carboxylated nitrile rubber
JP3162668B2 (ja) * 1997-02-04 2001-05-08 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンＥ２誘導体
AU7349298A (en) * 1997-06-23 1999-01-04 Pfizer Inc. Prostaglandin agonists
SE9702706D0 (sv) * 1997-07-11 1997-07-11 Pharmacia & Upjohn Ab Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
US6090847A (en) * 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
JP2001527063A (ja) * 1998-12-24 2001-12-25 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンＥ２誘導体
MXPA03000914A (es) * 2000-08-09 2003-10-06 Boehringer Ingelheim Pharma Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona.
ES2246419T3 (es) * 2001-11-05 2006-02-16 Allergan, Inc. Analogos de omega-cicloalquil-17-heteroaril-prostaglandina e2 como agonistas del receptor ep-2.
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
GB0329620D0 (en) 2003-12-22 2004-01-28 Pharmagene Lab Ltd EP2 receptor agonists
DK1856042T3 (da) * 2005-03-10 2012-09-17 Allergan Inc Substituerede gamma-lactamer som terapeutiske midler
US7592364B2 (en) * 2006-02-28 2009-09-22 Allergan, Inc. Substituted gamma lactams as therapeutic agents
AU2007226957B2 (en) * 2006-03-20 2013-08-15 Allergan, Inc. Substituted gamma lactams as prostaglandin EP2 agonists

Also Published As

Publication number Publication date
IL183360A0 (en) 2007-09-20
EP1819670B1 (en) 2012-08-08
NO20072662L (no) 2007-09-04
AR052264A1 (es) 2007-03-07
US20060205800A1 (en) 2006-09-14
US7091231B2 (en) 2006-08-15
US7799821B2 (en) 2010-09-21
JP2008523088A (ja) 2008-07-03
US20060148894A1 (en) 2006-07-06
CN101107225A (zh) 2008-01-16
PL383422A1 (pl) 2008-03-17
MX2007006690A (es) 2007-08-14
WO2006063179A1 (en) 2006-06-15
HK1114832A1 (en) 2008-11-14
TWI392666B (zh) 2013-04-11
NZ555352A (en) 2011-01-28
RU2007120520A (ru) 2009-01-20
CA2589864C (en) 2015-02-03
BRPI0518642A2 (pt) 2008-12-02
CA2589864A1 (en) 2006-06-15
JP5342142B2 (ja) 2013-11-13
EP1819670A1 (en) 2007-08-22
US20100317872A1 (en) 2010-12-16
PL216197B1 (pl) 2014-03-31
CN101107225B (zh) 2012-11-28
TW200633966A (en) 2006-10-01
DK1819670T3 (da) 2012-09-17
KR101367553B1 (ko) 2014-03-14
KR20070086001A (ko) 2007-08-27
US8044092B2 (en) 2011-10-25
RU2439055C2 (ru) 2012-01-10
AU2005314000B2 (en) 2012-06-14
ES2394838T3 (es) 2013-02-06
AU2005314000A1 (en) 2006-06-15
IL183360A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
ZA200704087B (en) 12-aryl prostaglandin analogs
IL176416A0 (en) Prostaglandin nitrooxyderivatives
ZA200700357B (en) Tetrapetide analogs
IL180101A0 (en) Epitope analogs
KR101434673B9 (ko) 할리콘드린 ｂ 유사체의 제조를 위한 중간체
IL181857A0 (en) Quinolone analogs
EP1610759A4 (en) SUBSTITUTED QUINOBENZOXAZINE ANALOGUES
GB0417401D0 (en) Stabilised prostaglandin composition
IL170742A0 (en) Somatostatin-dopamine chimeric analogs
ZA200710861B (en) Uses of prostacyclin analogs
GB0403819D0 (en) New compounds
AP2007003894A0 (en) Tetrapeptide analogs
GB0427403D0 (en) Novel compounds I
EP1810029A4 (en) Topiramate analogs
GB0418015D0 (en) New compounds
GB0413738D0 (en) Novel organofluorine compounds
TWI348370B (en) Piperidinyl prostaglandin e analogs
GB0403593D0 (en) Compounds
GB0403595D0 (en) Compounds
HK1105207A (en) Epitope analogs
GB0425829D0 (en) Antitumoral compounds
GB0424964D0 (en) Antitumoral compounds
GB0402312D0 (en) New antitumoral compounds
HUP0401467D0 (en) New compounds
GB0418014D0 (en) New compounds